• Tech Stock Insider
  • Posts
  • The Chip Toolmaker Priced Like a Cyclical, Growing Like a Software Company

The Chip Toolmaker Priced Like a Cyclical, Growing Like a Software Company

Small semi tool maker just crushed Q2. Watch the Q3 print in November for your real setup.

There's a niche semiconductor metrology name sitting inside every leading-edge AI chip line running in Taiwan and Korea right now. Q2 came in strong.

Bookings are outpacing revenue, and the Q3 print in early November is the window worth watching. Current price doesn't line up with what's actually underneath. Here's why.

Hidden AI Picks (Sponsored)

The obvious AI winners have already made headlines.

Chief Investment Strategist Alexander Green with The Oxford Club, believes the next wave could come from three lesser-known companies quietly dominating cybersecurity, retail automation and pharma.

He says investors should know these names before December 2026.

Click here to learn more

The Chip Toolmaker Priced Like a Cyclical, Growing Like a Software Company

Nova Ltd (NASDAQ: NVMI) is a specialty metrology player that competes directly with mid-cap peers like Onto Innovation (NYSE: ONTO) and Camtek (NASDAQ: CAMT), both of which just printed record quarters on AI packaging demand and now trade like every fund on the Street already did your homework.

Nova does the same job, sits inside the same tool racks, grows in the same end markets, and just delivered its own record Q2 on August 6 with revenue of $255 million and non-GAAP EPS of $2.51, alongside Q3 revenue guidance of $277 million to $287 million.

With the next earnings call scheduled for November 5, 2026, this is the setup you want to be positioned for.

Operational Overview and Recent Earnings

Nova sells the tools that measure atoms during chip manufacturing, specifically optical CD and X-ray metrology.

Every advanced node built at TSMC, Samsung, and Intel needs this step, and you're seeing demand for advanced packaging metrology run ahead of what fabs planned even six months ago.

Q2 was a beat on both the top and bottom line, and guidance came in ahead of consensus. But the beat alone isn't the story. Book-to-bill running above 1 is what should catch your eye.

Orders climbing faster than revenue means the installed base keeps compounding, and Q3 has room to beat again because the backlog is already there.

Action: Start accumulating your NVMI position ahead of the Q3 print in early November. Size in tranches, half now, half into the print if the setup holds. Add on any pullback tied to broader semi-cap volatility.

AI shift (Sponsored)

Artificial intelligence is changing the way companies operate—and one new initiative linked to Elon Musk is attracting attention.

According to a veteran market analyst, the biggest opportunity may not be the household names, but a little-known company supporting the technology behind the scenes.

His free briefing reveals the trend and the stocks he's watching.

Watch the Free Briefing

Why the Street Keeps Mispricing NVMI

Nova gets lumped into the semi-cap equipment basket, which trades on the WFE cycle. That framing misses what the company actually is.

Metrology is the smallest slice of the semi-cap pie, and it's the fastest growing. Every shrink to a smaller node means more measurement steps per wafer. Every advanced packaging line, and you're seeing a lot of them getting built for AI accelerators, needs Nova's tools.

That's why the multiple gap between NVMI and KLA doesn't make sense. Same customers, same tailwind, faster growth, cheaper stock. The gap screams misclassification, not skepticism.

Action: Watch the Q3 gross margin line closely. If it holds at or above Q2 levels, the software-like economics thesis gets validated and the multiple should re-rate.

Protect Purchasing Power (Sponsored)

When the U.S. left the gold standard in 1971, the rules of money changed almost overnight.

Today, with inflation concerns, heavy central-bank gold buying, and questions around the dollar, some investors are taking another look at physical gold for retirement diversification.

This free guide explains the history, the risks, and how eligible retirement funds may be used for gold without triggering an immediate taxable distribution.

See How Retirement Investors Are Adding Physical Gold Before the Next Big Shift

The Advanced Packaging Kicker Not Yet Modeled

Advanced packaging is the piece I don't think consensus has properly built into the model. HBM stacking, chiplet integration, hybrid bonding. All of it requires metrology steps that legacy packaging never needed.

Nova already sells into HBM lines at the big memory names. As HBM4 ramps in 2026 and 2027, the tool count per line goes up, not down.

Micron alone flagged HBM supply sold out through 2026, with demand extending to 2028 and $100 billion in strategic customer agreements. That's the demand curve Nova is selling picks and shovels into.

Action: Track memory capex commentary from Micron, SK Hynix, and Samsung on their next prints. Any upward revision flows directly into your Nova 2027 revenue setup.

Bear Case

Semi-cap is cyclical, and Nova isn't immune. If the industry rolls over, so does this stock, and so does your position.

Customer concentration is real. The top three customers likely make up a big chunk of revenue, and if any one of them pushes out orders, you feel it.

China export controls remain the wildcard, potentially clipping a mid-single-digit percentage of revenue. Size that hit before you add.

Valuation isn't cheap in absolute terms. Cheap relative to peers, sure, but a broader semi-cap correction takes NVMI with it regardless of fundamentals, and you along for the ride.

Competition from KLA is the structural risk. KLA dominates metrology overall, and if they push harder into Nova's niches, pricing power erodes. That is the thesis-killer to track.

Israel-based operations carry geopolitical risk that most US-listed peers don't share. Weigh that before sizing up.

Action: Hedge with a semi-cap ETF like SOXX if you want the thesis without single-name blowup risk. Size the position at 2 to 3 percent of the portfolio, not 10.

Why I Like the Setup Into November

The Q3 print in early November is the catalyst. Bookings tell you the top line is set up to beat. Advanced packaging exposure tells you the mix shift keeps margins moving the right direction.

And the valuation gap versus KLA and AMAT tells you the re-rating potential is there if the numbers land.

I'm not betting on a 100 percent move. I'm betting on a 20 to 30 percent re-rating over the next two quarters as the market re-classifies Nova out of the cyclical bucket and into the advanced-packaging pure-play bucket.

Much easier story for you to underwrite than a full semi-cycle call.

Setup Scorecard

Entry Zone: $365–$392

Target: $441

Stop Loss: Reassess below $353

Catalyst Timeline: Q3 2026 earnings, early November. Watch memory capex commentary from Micron and SK Hynix in the weeks prior.

Confidence Level: Medium-high. Fundamentals are set up. The main risk is a broader semi-cap drawdown pulling the name down regardless of the print.

That's our coverage for today; thanks for reading! Reply to this email with feedback or any tech stocks you want me to check out.

Best Regards,
—Noah Zelvis
Tech Stock Insider